Mol. Immunol.    

Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB/c mice.

Kardani K, Hashemi A, Bolhassani A

A licensed vaccine against human immunodeficiency virus-1 (HIV-1) infection has not become available up to now. Hence, it is more rational to use immu... Read More

Source: PubMed

---

---

Aten Primaria  2020 Jan 29  

[Where are the women in HIV/AIDS prevention campaigns in Spain? The importance of the gender perspective and affective-sexual diversity].

Obón-Azuara B, Gasch-Gallén Á, Gutiérrez-Cía I, Tomás-Aznar C

... Read More

Source: PubMed

---

Infect. Genet. Evol.  2020 Jan 29  

The impact of bone marrow stromal antigen-2 (BST2) gene variants on HIV-1 control in black South African individuals.

Dias BDC, Paximadis M, Martinson N, Chaisson RE, Ebrahim O, Tiemessen CT

Bone marrow stromal cell antigen 2 (BST2 or tetherin) is a host-encoded, interferon-inducible antiviral restriction factor which blocks the release of... Read More

Source: PubMed

---

J Pharm Sci  2020 Jan 29  

Integration of computational and experimental approaches to elucidate mechanisms of first-pass lymphatic drug sequestration and long-acting pharmacokinetics of the injectable triple-HIV drug combination TLC-ART 101.

Perazzolo S, Shireman LM, McConnachie LA, Koehn J, Kinman L, Lee W, Lane S, Collier AC, Shen DD, Ho RJY

TLC-ART101 is a long-acting triple-HIV drug combination of lopinavir-ritonavir-tenofovir combined in one nano-suspension intended for subcutaneous inj... Read More

Source: PubMed

---

AIDS Behav  2020 Jan 31  

Falling Through the Cracks: Risk Factors for Becoming Lost to HIV Care After Incarceration in a Southern Jail.

Tiruneh YM, Li X, Bovell-Ammon B, Iroh P, Flanigan TP, Montague BT, Rich JD, Nijhawan AE

Using a retrospective cohort analysis of inmates released from Dallas County Jail between January 2011 and November 2013, this study characterizes peo... Read More

Source: PubMed

---